3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer
Masao Takahashi1, Ken Nakazawa2, Yoko Usami2
1Department of Diagnostic Radiology, Saitama Medical University Hospital, Saitama, Japan.
Summary
A new 3-Fr catheter system enables superselective intra-arterial cisplatin infusion and radiotherapy (RADPLAT) for right maxillary sinus squamous cell carcinoma (MS-SCC). This minimally invasive approach via upper limb arteries proved feasible and effective in treating MS-SCC.
Area of Science:
- Interventional Radiology
- Oncology
- Vascular Surgery
Background:
- Maxillary sinus squamous cell carcinoma (MS-SCC) presents treatment challenges.
- Superselective intra-arterial chemotherapy combined with radiotherapy (RADPLAT) is a potential therapeutic strategy.
- Minimally invasive catheter-based delivery systems are crucial for targeted cancer treatment.
Purpose of the Study:
- To evaluate the efficacy and feasibility of a novel 3-Fr catheter system.
- To assess the system's utility for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT).
- To determine the system's applicability in treating right maxillary sinus squamous cell carcinoma (MS-SCC) via right upper limb artery access.
Main Methods:
- Retrospective analysis of 46 treatment sessions in eight MS-SCC patients.
- Utilized a 3-Fr sheath inserted into distal radial, conventional radial, or brachial arteries.
- Employed a coaxial catheter system with steerable microcatheters for precise arterial selection and cisplatin infusion.
Main Results:
- Successful cisplatin infusion and coil embolization were achieved in all sessions.
- The catheter system facilitated superselective targeting of external carotid artery branches.
- Minor complications included arterial occlusion at sheath sites (29.4% distal radial, 33.3% conventional radial); no other major complications occurred.
Conclusions:
- The 3-Fr catheter system with a steerable microcatheter is a feasible method for RADPLAT.
- Right upper limb artery access provides an effective route for treating right MS-SCC.
- This technique offers a minimally invasive option for targeted MS-SCC therapy.


